Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 5INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Triple Negative Breast Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Lymphoma, Non-Hodgkin 1Lymphoma, AIDS-Related 1HIV Infections 1Dendritic Cell Sarcoma, Interdigitating 1

Interventions

Cyclophosphamide 2042Radiotherapy 1859Cisplatin 1825Carboplatin 1533Gemcitabine 1434Paclitaxel 1289Bevacizumab 1270Docetaxel 1202pembrolizumab 1199Oxaliplatin 1160Capecitabine 1144Fluorouracil 1061Dexamethasone 971Rituximab 919Nivolumab 908Magnetic Resonance Spectroscopy 862Etoposide 839Doxorubicin 823Drug Therapy 792Radiosurgery 776Irinotecan 775Cytarabine 736fludarabine 716Leucovorin 676Lenalidomide 608fludarabine phosphate 564Temozolomide 552Radiation 541Filgrastim 540Cetuximab 537

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
OTHER × Interventional × efavirenz × Clear all
NCT05076682 2025-12-03

Renaissance

Fudan University

Phase 2 Recruiting
80 enrolled
Breast

Triple Negative Breast Neoplasms

NCT00964171 2025-08-28

PANTER

Institut Bergonié

Phase 2 Completed
19 enrolled 11 charts
Gastrointestinal

Pancreatic Neoplasms

NCT00964002 2022-05-16

FAVE

Institut Bergonié

Phase 2 Completed
61 enrolled 6 charts
Genitourinary

Prostatic Neoplasms

NCT01878890 2021-01-27

ESCALE

Institut Bergonié

Phase 1 Completed
25 enrolled 11 charts
Lymphoid

Lymphoma, Non-Hodgkin

NCT00799136 2013-09-12

CATCH

Ontario Clinical Oncology Group (OCOG)

Phase 2 Completed
6 enrolled
LymphoidSarcoma

HIV Infections, Lymphoma, AIDS-Related, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡